In Los Angeles, New York, Houston, Philadelphia, and Washington, D.C., a National Institutes of Health funded clinical trial, known as INTEGRA, is evaluating the efficacy of delivering integrated HIV and substance use disorder care via mobile clinics.
Clinicians can now access up-to-date evidence-based office-based addiction treatment recommendations for treating opioid use disorder (OUD) on a smartphone app.
This policy brief identified states potentially at risk for an HIV or HCV outbreak and used data from multiple sources to examine rural-urban differences in 1) state-level infectious disease surveillance, prevention activities, and collaboration with stakeholders; 2) local health department-level
To address the infectious disease consequences of the opioid crisis in the U.S., a public workshop titled Integrating Infectious Disease Considerations with Response to the Opioid Epidemic was convened on March 12 and 13, 2018, by the National Academies of Sciences, Engineering, and Medicine.
This ready-to-use training package is designed to provide HIV clinicians (including physicians, dentists, nurses, therapists and social workers, and counselors, specialists, and case managers) with an overview of the challenges and strategies for change in working with individuals living with HIV
This ready-to-use training package is designed to provide HIV clinicians (including physicians, dentists, nurses, therapists and social workers, and counselors, specialists, and case managers) with an overview of the opioid crisis and HIV.
This ready-to-use training package is designed to provide HIV clinicians (including physicians, dentists, nurses, therapists and social workers, and counselors, specialists, and case managers) with a detailed overview of screening patients for at‐risk alcohol and other drug use and conducting a b
The ready-to-use training package is designed to provide HIV clinicians (including physicians, dentists, nurses, therapists and social workers, and counselors, specialists, and case managers) with an overview of the neurobiology of addiction, the impact of HIV on the brain and central nervous sys
